The realities of diabetes treatment

Advancements in management
Diabetes remains one of the most misunderstood chronic conditions, with Namibia recording thousands of new cases each year.
Patricia van Rooi

The World Health Organisation (WHO) defines diabetes as a chronic disease that occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces.


Insulin regulates blood glucose, while uncontrolled diabetes can cause hyperglycaemia, or raised blood sugar, which over time may damage various body systems, particularly the nerves and blood vessels.


Treatment advancement and accessibility

One question almost every diabetic has heard is: "Are you allowed to eat that?" Fortunately, advancements in diabetes management allow many people living with the condition to lead normal, active lives.


For many, a glucose testing machine is the first introduction to managing diabetes. This pocket-sized device measures glucose through a finger-prick blood test. However, an increasingly popular alternative is the Continuous Glucose Monitor (CGM), a wearable device that automatically tracks blood sugar levels throughout the day and night.


A CGM consists of three main components: a small sensor inserted beneath the skin, usually on the upper arm or abdomen; a transmitter that sends readings wirelessly; and a receiver, often a smartphone application, which displays glucose levels, trends and historical readings.


Diabetes nurse educator Penny Becker explained that the sensor contains a thin filament coated with an enzyme that reacts with glucose in the interstitial fluid surrounding the body's cells. Through a biochemical process, it estimates glucose levels and sends the information to a receiver.


Despite being a major advancement, CGMs are not always 100% accurate. Becker explained that sensors can produce unreliable readings if they shift, become dislodged or experience pressure, such as when someone sleeps on them. In some cases, they may fail and require replacement.


Consequently, users may still need finger-prick tests to verify readings, particularly when results seem questionable or do not correspond with how they feel. Sensors may also be less accurate during their first day of use before becoming more reliable.


Choosing the right device is equally important, as CGMs differ in their approved age limits and medical suitability. Some are suitable for children as young as two, while others have restrictions relating to pregnancy or certain medications.


Becker stressed the importance of professional guidance to ensure patients use technology suited to their individual needs. Healthcare workers must also be adequately educated about available products to help patients make informed decisions.


While CGMs make monitoring glucose levels less daunting, accessibility remains a major obstacle.


The cost of modern diabetes technology


Despite its benefits, affordability remains one of the biggest challenges facing patients, particularly those relying on public healthcare services.



Becker explained that developing medical technology requires significant investment, with companies needing to recover development costs. Consequently, the latest innovations are often expensive when first introduced.


Over time, increased competition and improved technology can help reduce prices, making devices more accessible. However, many patients still cannot afford them.


While certain private medical aid plans may provide access to these advancements, much of the general public remains without the technology needed to manage diabetes more conveniently. Greater competition and continued innovation could eventually make treatment more affordable and accurate.

But that is not where it stops.


People living with Type 1 diabetes rely on man-made insulin to regulate their glucose levels, traditionally administered through multiple daily injections.

"Having lived with diabetes for the past 22 years, it's a norm for me. It's not even a routine but just a habit. There are days where I think I forgot to take my insulin, but it's so incorporated that forgetting isn't really something I do anymore. I tend to forget I'm a diabetic, and when I pull out my insulin, people tend to stare. Pretty funny sometimes," says Type 1 diabetic Michaiyla Hansen.


Advancements have also introduced insulin pumps, offering some patients an alternative to multiple daily injections. These small, computerised devices deliver rapid-acting insulin continuously beneath the skin, reducing the need for traditional injections.


Modern pumps can also connect to CGMs to form automated insulin delivery (AID) systems, often called an "artificial pancreas". These systems can adjust insulin delivery based on glucose readings, reducing insulin when levels are dropping and increasing delivery when levels rise.


However, insulin pumps and their monthly consumables, including infusion sets, sensors and reservoirs, remain expensive, limiting access largely to patients who can afford them or have suitable private medical aid coverage.


Ultimately, diabetes is a different journey for every individual. Although technology continues to transform treatment, affordability, accessibility, accuracy and education remain crucial challenges.


In the words of diabetes influencer Matt Rehrig: "The day you get diagnosed with diabetes is the day you manually start preventing your own death, so consider yourself one of the elite few with that power."